Impact of lockdown on the microbiological status of the hospital water network during COVID-19 pandemic.


Journal

Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621

Informations de publication

Date de publication:
12 2020
Historique:
received: 26 06 2020
revised: 09 09 2020
accepted: 10 09 2020
pubmed: 26 9 2020
medline: 20 11 2020
entrez: 25 9 2020
Statut: ppublish

Résumé

The COVID-19 pandemic started in China in early December 2019, and quickly spread around the world. The epidemic gradually started in Italy at the end of February 2020, and by May 31, 2020, 232,664 cases and 33,340 deaths were confirmed. As a result of this pandemic, the Italian Ministerial Decree issued on March 11, 2020, enforced lockdown; therefore, many social, recreational, and cultural centers remained closed for months. In Apulia (southern Italy), all non-urgent hospital activities were suspended, and some wards were closed, with a consequent reduction in the use of the water network and the formation of stagnant water. This situation could enhance the risk of exposure of people to waterborne diseases, including legionellosis. The purpose of this study was to monitor the microbiological quality of the water network (coliforms, E. coli, Enterococci, P. aeruginosa, and Legionella) in three wards (A, B and C) of a large COVID-19 regional hospital, closed for three months due to the COVID-19 emergency. Our study revealed that all three wards' water network showed higher contamination by Legionella pneumophila sg 1 and sg 6 at T1 (after lockdown) compared to the period before the lockdown (T0). In particular, ward A at T1 showed a median value = 5600 CFU/L (range 0-91,000 CFU/L) vs T0, median value = 75 CFU/L (range 0-5000 CFU/L) (p-value = 0.014); ward B at T1 showed a median value = 200 CFU/L (range 0-4200 CFU/L) vs T0, median value = 0 CFU/L (range 0-300 CFU/L) (p-value = 0.016) and ward C at T1 showed a median value = 175 CFU/L (range 0-22,000 CFU/L) vs T0, median value = 0 CFU/L (range 0-340 CFU/L) (p-value < 0.001). In addition, a statistically significant difference was detected in ward B between the number of positive water samples at T0 vs T1 for L. pneumophila sg 1 and sg 6 (24% vs 80% p-value < 0.001) and for coliforms (0% vs 64% p-value < 0.001). Moreover, a median value of coliform load resulted 3 CFU/100 ml (range 0-14 CFU/100 ml) at T1, showing a statistically significant increase versus T0 (0 CFU/100 ml) (p-value < 0.001). Our results highlight the need to implement a water safety plan that includes staff training and a more rigorous environmental microbiological surveillance in all hospitals before occupying a closed ward for a longer than one week, according to national and international guidelines.

Identifiants

pubmed: 32976823
pii: S0013-9351(20)31128-2
doi: 10.1016/j.envres.2020.110231
pmc: PMC7511218
pii:
doi:

Substances chimiques

Water 059QF0KO0R

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

110231

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Acta Biomed. 2020 May 11;91(2):13-22
pubmed: 32420919
Int J Environ Res Public Health. 2020 May 16;17(10):
pubmed: 32429432
Microb Ecol. 1996 Jul;32(2):203-28
pubmed: 8688009
BMC Public Health. 2010 Nov 02;10:660
pubmed: 21044294
Am J Infect Control. 2012 Jun;40(5):396-407
pubmed: 21908073
Environ Res. 2016 Apr;146:47-50
pubmed: 26717079
J Hosp Infect. 2011 Jan;77(1):47-51
pubmed: 21131100
J Hosp Infect. 2020 Jan;104(1):40-45
pubmed: 31419468
Environ Res. 2019 Mar;170:215-221
pubmed: 30594053
Int J Hyg Environ Health. 2018 Jun;221(5):764-774
pubmed: 29729999
Disaster Med Public Health Prep. 2020 Jun;14(3):372-376
pubmed: 32207676
Environ Monit Assess. 2016 Nov;188(11):638
pubmed: 27783346
Environ Res. 2018 Oct;166:55-60
pubmed: 29864633
Ann Ig. 2017 Mar-Apr;29(2):92-100
pubmed: 28244578
Ann Clin Lab Sci. 1987 May-Jun;17(3):150-6
pubmed: 3606021
Ann Ig. 2019 Sep-Oct;31(5):474-481
pubmed: 31304527
J Travel Med. 2020 May 18;27(3):
pubmed: 32297939
Environ Res. 2015 Oct;142:586-90
pubmed: 26298602

Auteurs

Osvalda De Giglio (O)

Regional Reference Laboratory of Clinical and Environmental Surveillance of Legionellosis, Department of Biomedical Science and Human Oncology, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124, Bari, Italy. Electronic address: osvalda.degiglio@uniba.it.

Giusy Diella (G)

Regional Reference Laboratory of Clinical and Environmental Surveillance of Legionellosis, Department of Biomedical Science and Human Oncology, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124, Bari, Italy. Electronic address: giusy.diella@uniba.it.

Marco Lopuzzo (M)

Regional Reference Laboratory of Clinical and Environmental Surveillance of Legionellosis, Department of Biomedical Science and Human Oncology, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124, Bari, Italy. Electronic address: marcolopuzzo@gmail.com.

Francesco Triggiano (F)

Regional Reference Laboratory of Clinical and Environmental Surveillance of Legionellosis, Department of Biomedical Science and Human Oncology, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124, Bari, Italy. Electronic address: francesco.triggiano@uniba.it.

Carla Calia (C)

Regional Reference Laboratory of Clinical and Environmental Surveillance of Legionellosis, Department of Biomedical Science and Human Oncology, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124, Bari, Italy. Electronic address: carla.calia@uniba.it.

Chrysovalentinos Pousis (C)

Regional Reference Laboratory of Clinical and Environmental Surveillance of Legionellosis, Department of Biomedical Science and Human Oncology, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124, Bari, Italy. Electronic address: vpousis@gmail.com.

Fabrizio Fasano (F)

Regional Reference Laboratory of Clinical and Environmental Surveillance of Legionellosis, Department of Biomedical Science and Human Oncology, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124, Bari, Italy. Electronic address: fabrizio.fasano1979@libero.it.

Giuseppina Caggiano (G)

Regional Reference Laboratory of Clinical and Environmental Surveillance of Legionellosis, Department of Biomedical Science and Human Oncology, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124, Bari, Italy. Electronic address: giuseppina.caggiano@uniba.it.

Giuseppe Calabrese (G)

A.O.U. Policlinico di Bari, Italy. Electronic address: giuseppe.calabrese@policlinico.ba.it.

Vincenza Rafaschieri (V)

A.O.U. Policlinico di Bari, Italy. Electronic address: vincenza.rafaschieri@policlinico.ba.it.

Federica Carpagnano (F)

A.O.U. Policlinico di Bari, Italy. Electronic address: dr.fedecarpagnano@gmail.com.

Matilde Carlucci (M)

A.O.U. Policlinico di Bari, Italy. Electronic address: matilde.carlucci@policlinico.ba.it.

Loreto Gesualdo (L)

Department of Emergency and Organ Transplantation-Nephrology, Dialysis and Transplantation Unit, University of Bari Aldo Moro, Bari, 70124, Italy. Electronic address: loreto.gesualdo@uniba.it.

Maria Luisa Ricci (ML)

Department of Infectious Diseases, Istituto Superiore di Sanità, Viale Regina Elena, 299-00161, Rome, Italy. Electronic address: marialuisa.ricci@iss.it.

Maria Scaturro (M)

Department of Infectious Diseases, Istituto Superiore di Sanità, Viale Regina Elena, 299-00161, Rome, Italy. Electronic address: maria.scaturro@iss.it.

Maria Cristina Rota (MC)

Department of Infectious Diseases, Istituto Superiore di Sanità, Viale Regina Elena, 299-00161, Rome, Italy. Electronic address: mariacristina.rota@iss.it.

Lucia Bonadonna (L)

Department of Environment and Health, Istituto Superiore di Sanità, Viale Regina Elena, 299-00161, Rome, Italy. Electronic address: lucia.bonadonna@iss.it.

Luca Lucentini (L)

Department of Environment and Health, Istituto Superiore di Sanità, Viale Regina Elena, 299-00161, Rome, Italy. Electronic address: luca.lucentini@iss.it.

Maria Teresa Montagna (MT)

Regional Reference Laboratory of Clinical and Environmental Surveillance of Legionellosis, Department of Biomedical Science and Human Oncology, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124, Bari, Italy. Electronic address: mariateresa.montagna@uniba.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH